Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
GPR33 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 33 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR33 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR173 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 173 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR173 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR19 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 19 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR19 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR21 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 21 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR21 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR174 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 174 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR174 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR150 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 150 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR150 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR162 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 162 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR162 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR152 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 152 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR152 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR160 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 160 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR160 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR132 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 132 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR132 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR148 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 148 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR148 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR141 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 141 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR141 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
14
15
16
17
18
>>
1503
>